Gastrectomy Clinical Trial
Official title:
Impact of Low Perfusion by High Intraabdominal Pressure and Low Blood Pressure on Stapling Quality Measured as Thickness Difference Between Staples and Stomach Wall and by Bursting Pressure of Excluded Stomach
the excluded stomach during sleeve gastrectomy can be investigated post removal outside the patient. During stapling it is common to reduce systolic arterial blood pressure (SAP) below 100 mmHg to reduce peritoneal perfusion and have better compression. Higher intra abdominal pressures reduce also the peritoneal and mucosal perfusion and might help to improve stapling compression. Stapling compression can be evaluated by measuring stapling thickness and compare it with stomach wall thickness or by measuring leaks during leak test or better outside the patient on the excised stomach with a bursting pressure.
Patients are randomized to two groups: group standard perfusion means that the SAP is kept
between 100 and 140 mmHg by adapting depth of anesthesia, by level of post expiratory
pressure or by giving vasoconstriction.
low perfusion group means that
1. systolic blood pressure is kept below 100 mmHg from the first linear staple till the
last by using a Clevidipine infusion to regulate the blood pressure accurate just below
100 mmHg for a short time while needed.
2. goal directed fluid therapy using 100 ml/h fluid intravenous and extra load of fluid if
pulse pressure variation > 20 %
3. increase intra abdominal pressure (IAP) up to 20 mmHg inly during stapling and return to
minimum IAP needed to achieve 3 liter workspace.
The resected stomach is removed and analyzed outside the body before throwing away:
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05161572 -
Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer
|
Phase 2 | |
Active, not recruiting |
NCT04422236 -
A Post-market, Observational Registry With the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Bariatric Surgery
|
||
Completed |
NCT00827931 -
Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery
|
Phase 4 | |
Completed |
NCT01257711 -
A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer
|
N/A | |
Not yet recruiting |
NCT06062225 -
Protocol for Comparing the Efficacy of Three Reconstruction Methods of the Digestive Tract After Proximal Gastrectomy
|
N/A | |
Completed |
NCT00885781 -
Efficacy and Safety Comparison Between SMOFlipid and Lipovenoes MCT
|
Phase 4 | |
Not yet recruiting |
NCT05071755 -
Gastrectomy Outcomes in Elderly Patients
|
||
Recruiting |
NCT04798820 -
The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING)
|
N/A | |
Recruiting |
NCT04295473 -
Reduced Port Laparoscopic Gastrectomy for Gastric Cancer
|
N/A | |
Recruiting |
NCT02068833 -
Resolution of Microalbuminuria and Dysmetabolism Following Bariatric Surgery: Prospective Study
|
N/A | |
Recruiting |
NCT01142271 -
Comparison of Billroth-I and Roux-en-Y Reconstruction After Distal Subtotal Gastrectomy
|
Phase 3 | |
Completed |
NCT03939819 -
Endoscopic vs. Suction Device Calibration in Sleeve Gastrectomy
|
N/A | |
Recruiting |
NCT01657812 -
A Comparison of Dexmedetomidine and Epidural Anesthesia Under General Anesthesia in Patients Undergoing Gastrectomy
|
Phase 4 | |
Withdrawn |
NCT00622804 -
Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy
|
Phase 3 | |
Recruiting |
NCT03708783 -
Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for AGC
|
N/A | |
Recruiting |
NCT06403540 -
The Impact of Laparotomy and Analgesia Methods on Diaphragm
|
||
Completed |
NCT03436082 -
Post-Market Surveillance With a Novel mHealth Platform
|
||
Recruiting |
NCT06058442 -
The Pancreatic Enzymes After Gastrectomy Trial
|
Phase 3 | |
Terminated |
NCT02836353 -
Metabolic Consequences of Gastrointestinal Surgery
|
N/A | |
Unknown status |
NCT02503826 -
The Efficacy and Optimal Dose of Sufentanil in Patient Controlled Analgesia After Moderate Surgery
|
Phase 4 |